Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report

被引:0
作者
Federico, Seragnoli [1 ,2 ]
Geo, Martignoni [3 ]
Entela, Martignoni [3 ]
Bachmann, Silke [1 ,4 ]
Elisa, Rabitti [5 ]
Silvio, Cavuto [6 ]
Zoe, Dubus [7 ]
Louise, Penzenstadler [1 ]
Gabriel, Thorens [1 ]
Joel, Billieux [2 ]
Daniele, Zullino [1 ,8 ]
机构
[1] Geneva Univ Hosp, Psychiat Dept, Geneva, Switzerland
[2] Univ Lausanne, Inst Psychol, Lausanne, Switzerland
[3] Private practice, Gordola, Switzerland
[4] Univ Hosp Halle, Dept Psychiat, Halle, Germany
[5] Azienda USL IRCCS Reggio Emilia, Psychooncol Unit, Reggio Emilia, Italy
[6] Azienda USL IRCCS Reggio Emilia, Clin Trial Ctr, Stat Unit, SOC Infrastruct Res & Stat, Reggio Emilia, Italy
[7] USASK, Coll Arts & Sci, Dept Hist, Saskatoon, SK, Canada
[8] Univ Geneva, Med Dept, Geneva, Switzerland
来源
CLINICAL CASE REPORTS | 2024年 / 12卷 / 09期
关键词
home treatment; palliative care; psychedelic; psychedelic-assisted therapy; throat cancer; MDMA ECSTASY; DOUBLE-BLIND; PSILOCYBIN; ANXIETY; NEUROTOXICITY; EFFICACY; DISORDER; SAFETY;
D O I
10.1002/ccr3.9305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key Clinical MessageThis case study describes the feasibility and safety of psychedelic-assisted therapy (PAT) as a home-based intervention for a patient with throat cancer experiencing significant existential distress. The patient tolerated the intervention well. This case supports the feasibility and safety of PAT for patients with life-threatening conditions in a home setting.AbstractPsychedelic-assisted therapy (PAT), as it is practiced today, merges traditional psychotherapeutic techniques with the use of psychedelics such as LSD, psilocybin, or MDMA with the aim of unlocking deeper insights in patients and treating mental conditions that are resistant to other forms of therapy. The present case study describes the safety of PAT as a home-based intervention for a patient with throat cancer experiencing significant existential distress. The patient tolerated the intervention well and was asked to report on measures of anxiety, depression, and distress related to his somatic condition. The observations provided by this clinical case report align with previous findings, suggesting that PAT can be safely applied to potentially provide relief from existential distress in patients with life-threatening conditions. As this is a single-case study, generalizations should be made cautiously. Moreover, placebo effects, expectancy effects, and the natural course of the disease may influence outcomes. Future research should consider controlled trials to ascertain the efficacy and safety of such interventions in diverse settings.
引用
收藏
页数:11
相关论文
共 56 条
  • [1] Aicher H., 2024, Swiss Archives of Neurology, Psychiatry and Psychotherapy, DOI [10.4414/sanp.2024.1488043038, DOI 10.4414/SANP.2024.1488043038]
  • [2] Aicher HD, 2024, PSYCHOTHERAPIE, DOI 10.1007/s00278-024-00711-y
  • [3] Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis
    Beaussant, Yvan
    Tarbi, Elise
    Nigam, Kabir
    Miner, Skye
    Sager, Zachary
    Sanders, Justin J.
    Ljuslin, Michael
    Guerin, Benjamin
    Thambi, Paul
    Tulsky, James A.
    Agrawal, Manish
    [J]. CANCER, 2024, 130 (07) : 1147 - 1157
  • [4] Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research
    Bender, David
    Hellerstein, David J.
    [J]. PSYCHOPHARMACOLOGY, 2022, 239 (06) : 1907 - 1932
  • [5] Bisbee CynthiaCarson., 2018, PSYCHEDELIC PROPHETS
  • [6] Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial
    Bogenschutz, Michael P.
    Ross, Stephen
    Bhatt, Snehal
    Baron, Tara
    Forcehimes, Alyssa A.
    Laska, Eugene
    Mennenga, Sarah E.
    O'Donnell, Kelley
    Owens, Lindsey T.
    Podrebarac, Samantha
    Rotrosen, John
    Tonigan, J. Scott
    Worth, Lindsay
    [J]. JAMA PSYCHIATRY, 2022, 79 (10) : 953 - 962
  • [7] Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism
    Bogenschutz, Michael P.
    Forcehimes, Alyssa A.
    [J]. JOURNAL OF HUMANISTIC PSYCHOLOGY, 2017, 57 (04) : 389 - 414
  • [8] Classic hallucinogens in the treatment of addictions
    Bogenschutz, Michael P.
    Johnson, Matthew W.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 64 : 250 - 258
  • [9] Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
    Bogenschutz, Michael P.
    Forcehimes, Alyssa A.
    Pommy, Jessica A.
    Wilcox, Claire E.
    Barbosa, P. C. R.
    Strassman, Rick J.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (03) : 289 - 299
  • [10] Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies
    Bradberry, Mazdak M.
    Gukasyan, Natalie
    Raison, Charles L.
    [J]. JAMA PSYCHIATRY, 2022, 79 (06) : 525 - 527